Skip to main content
SpringerLink
Log in

PET in Lung Cancer

  • Chapter
PET/CT

  • 1309 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. What are the key statistics for lung cancer? American Cancer Society (www.cancer.org); 2005 Accessed March 2005.

    Google Scholar 

  2. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111(6):1710–1717.

    PubMed  CAS  Google Scholar 

  3. Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999;67(4):927–932.

    Article  PubMed  CAS  Google Scholar 

  4. Non-small cell lung cancer cellular classification. National Cancer Institute (www.cancer.gov); 2005 Accessed April 2005.

    Google Scholar 

  5. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, sixth edition. New York: Springer-Verlag; 2002.

    Google Scholar 

  6. Medicare Coverage Homepage. Centers for Medicare and Medicaid Services (www.cms.hhs.gov/coverage/); 2005 Accessed April 2005.

    Google Scholar 

  7. Leef JL, 3rd, Klein JS. The solitary pulmonary nodule. Radiol Clin North Am 2002;40(1):123–143, ix.

    Article  PubMed  Google Scholar 

  8. Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993;68(4):378–385.

    PubMed  CAS  Google Scholar 

  9. Viggiano RW, Swensen SJ, Rosenow EC, 3rd. Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1992;13(1):83–95.

    PubMed  CAS  Google Scholar 

  10. Henschke CI, Yankelevitz DF, Kostis WJ. CT screening for lung cancer. Semin Ultrasound CT MR 2003;24(1):23–32.

    Article  PubMed  Google Scholar 

  11. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 1993;186(2):415–422.

    PubMed  CAS  Google Scholar 

  12. Woodring JH, Fried AM, Chuang VP. Solitary cavities of the lung: diagnostic implications of cavity wall thickness. AJR Am J Roentgenol 1980;135(6):1269–1271.

    PubMed  CAS  Google Scholar 

  13. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214(1):73–80.

    PubMed  CAS  Google Scholar 

  14. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35(11):1771–1776.

    PubMed  CAS  Google Scholar 

  15. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16(3):1075–1084.

    PubMed  CAS  Google Scholar 

  16. Goldsmith SJ, Kostakoglu L. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. Semin Ultrasound CT MR 2000;21(2):129–138.

    Article  PubMed  CAS  Google Scholar 

  17. Ahuja V, Coleman RE, Herndon J, Patz EF, Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83(5):918–924.

    Article  PubMed  CAS  Google Scholar 

  18. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285(7):914–924.

    Article  PubMed  CAS  Google Scholar 

  19. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212(3):803–809.

    PubMed  CAS  Google Scholar 

  20. Cheran SK, Herndon JE, 2nd, Patz EF, Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004;44(3):317–325.

    Article  PubMed  Google Scholar 

  21. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76(3):861–866.

    Article  PubMed  Google Scholar 

  22. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s — meta-analytic comparison of PET and CT. Radiology 1999;213(2):530–536.

    PubMed  CAS  Google Scholar 

  23. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM. [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000]. Pneumologie 2001;55(8):367–377.

    Article  PubMed  CAS  Google Scholar 

  24. Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14(6):1376–1380.

    Article  PubMed  CAS  Google Scholar 

  25. MacManus MP, Hicks RJ, Matthews JP, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2003;21(7):1285–1292.

    Article  Google Scholar 

  26. Cerfolio RJ, Bryant AS, Winokur TS, Ohja B, Bartolucci AA. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg 2004;78(6):1903–1909; discussion 1909.

    Article  PubMed  Google Scholar 

  27. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348(25):2500–2507.

    Article  PubMed  Google Scholar 

  28. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003;57(3):853–863.

    Article  PubMed  Google Scholar 

  29. Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998;114(4):1105–1111.

    PubMed  CAS  Google Scholar 

  30. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42(9):1412–1417.

    PubMed  CAS  Google Scholar 

  31. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43(7):871–875.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor and Department of Radiology, Director of Nuclear Medicine)

Authors
  1. Ronald B. Workman Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Edward Coleman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident) (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor Department of Radiology and Director of Nuclear Medicine) (Professor Department of Radiology and Director of Nuclear Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Workman, R.B., Coleman, R.E. (2006). PET in Lung Cancer. In: Workman, R.B., Coleman, R.E. (eds) PET/CT. Springer, New York, NY . https://doi.org/10.1007/978-0-387-38335-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38335-4_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32166-0

  • Online ISBN: 978-0-387-38335-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation